MedPath

Alberta Health Services

Alberta Health Services logo
🇨🇦Canada
Ownership
Private
Established
2009-04-01
Employees
10K
Market Cap
-
Website
http://www.albertahealthservices.ca

Onco-Innovations Partners with University of Alberta to Advance PNKP Inhibitor Research for Glioblastoma Treatment

Onco-Innovations has entered into a research agreement with the University of Alberta and Cross Cancer Institute to expand preclinical studies of its PNKP inhibitor technology for hard-to-treat cancers, beginning with glioblastoma multiforme.

Breakthrough Gene Therapy Eliminates Need for Enzyme Replacement in Fabry Disease Patients

Canadian researchers have successfully developed a one-time gene therapy treatment for Fabry disease that restored enzyme production to near-normal levels in all five trial participants within one week.

© Copyright 2025. All Rights Reserved by MedPath